Dr. Jaff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Estate Drive
Apartment 201
Chestnut Hill, MA 02467Phone+1 617-894-2922Fax+1 617-890-1870
Summary
- I am a board certified internist and vascular medicine specialist. I served as the President of Newton-Wellesley Hospital, a large academic community hospital in Newton, Massachusetts, part of Partners Healthcare from October 2016-December 2019. In January 2020, I became the Chief Medical Officer and Vice President of Clinical Affairs, Technology and Innovation for Peripheral Interventions at Boston Scientific Corporation. I am a full Professor of Medicine at Harvard Medical School and was the founder of VasCore, the world's largest vascular ultrasound core laboratory (www.vascore.org).
I have published over 300 peer-reviewed manuscripts and 10 textbooks.
Education & Training
- Harvard Business SchoolGraduate, General Management Program, 2010
- Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 1989 - 1990
- Cleveland Clinic FoundationResidency, Internal Medicine, 1986 - 1989
- Genesys Regional Medical Center - FlintInternship, Transitional Year, 1985 - 1986
- A. T. Still University Kirksville College of Osteopathic MedicineClass of 1985
- Dickinson CollegeB.S., Biology, Cum Laude, 1980
Certifications & Licensure
- MA State License 2004 - 2026
- AZ State License 1998 - 2010
- OH State License 1986 - 2008
- RI State License 2005 - 2006
- NJ State License 1996 - 2005
- FL State License 1986 - 2004
- NY State License 1986 - 2004
- American Board of Internal Medicine Internal Medicine
- National Board of Physicians and Surgeons Internal Medicine
- Join now to see all
Awards, Honors, & Recognition
- Paul and Phyllis Fireman Chair in Vascular Medicine (Endowed Chair) Massachusetts General Hospital, 2014
- 18th Annual Recipient of the Charles J. Tegtmeyer Award, Career Recognition Award (First Non-Interventional Vascular Specialist Recipient) International Symposium for Endovascular Therapy, 2012
- Charles Tegtmeyer, MD Award International Symposium on Endovascular Therapy, 2012
- Join now to see all
Clinical Trials
- The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Renal Stent to Treat Renal Artery Stenosis Start of enrollment: 2007 Aug 01
Publications & Presentations
PubMed
- 278 citationsDurability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA.John R. Laird, Peter Schneider, Gunnar Tepe, Marianne Brodmann, Thomas Zeller
Journal of the American College of Cardiology. 2015-12-01 - 122 citationsAn Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consen...Michael R. Jaff, Christopher J. White, William R. Hiatt, Gerry Fowkes, John A. Dormandy
Vascular Medicine. 2015-08-12 - 78 citationsSUPERB final 3-year outcomes using interwoven nitinol biomimetic supera stent.Lawrence A. Garcia, Kenneth R Rosenfield, Christopher Metzger, Frank Zidar, Ashish Pershad
Catheterization and Cardiovascular Interventions. 2017-06-01
Journal Articles
- Nitinol Self-Expanding Stents for the Treatment of Obstructive Superficial Femoral Artery Disease: Three-Year Results of the RELIABLE Japanese Multicenter StudyMichael Jaff, DO, J-STAGE
- Treatment of Submassive and Massive Pulmonary Embolism: A Clinical Practice Survey from the Second Annual Meeting of the Pulmonary Embolism Response Team ConsortiumKenneth Rosenfield, Geoffrey D Barnes, Michael R Jaff, Thomas M Todoran, Christopher Kabrhel, Rachel P Rosovsky, Jay Giri, Journal of Thrombosis and Thrombolysis
- Accreditation status and geographic location of outpatient vascular testing facilities among Medicare beneficiaries: the VALUE (Vascular Accreditation, Location and Ut...Rundek T, Brown SC, Wang K, Dong C, Farrell MG, Heller GV, Gornik HL, Hutchisson M, Needleman L, Benenati JF, Jaff MR, Meier GH, Perese S, Bendick P, Hamburg NM, Lohr ..., Vasc Med, 9/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Carotid artery stenting and carotid endarterectomy are comparable among Medicare beneficiaries treated in routine clinical practice.Jalbert JJ, Nguyen LL, Gerhard-Herman MD, Williams LA, Chen CY, Kumamaru H, Rothman RT, Jaff MR, Seeger JD, Benenati J, Schneider PS, Aronow HD, Johnston JA, Brott TG,..., American Heart Association, Chicago, IL, 11/1/2014
- Economic analysis of the Stellarex drug coated balloon compared to uncoated balloon for treatment of femoropopliteal peripheral artery disease.Jaff MR, Wallace KL, Zeller T, Transcatheter Cardiovascular Therapeutics, Washington, DC, 9/1/2014
- 30-day mortality after carotid artery stenting (CAS) in trial versus real-world settings.Jalbert JJ, Nguyen LL, Gerhard-Herman MD, Jaff MR, Seeger JD, Kumamaru H, Williams LA, Liu J, Chen CY, Johnston JA, Aronow HD, Setoguchi S, International Stroke Conference, San Diego, CA, 1/1/2014
- Join now to see all
Lectures
- Peripheral Vascular Diseases—A Case Based ApproachCambridge, MA - 1/1/2014
- Diagnosis and Treatment of Peripheral Artery Disease, Management of Venous Thromboembolic DiseaseHolyoke, MA - 1/1/2014
- The Introduction to Vascular TestingMassachusetts General Hospital, Boston, MA - 1/1/2014
- Join now to see all
Press Mentions
- Surveying the Below-the-Knee Revascularization Trial LandscapeMay 16th, 2024
- Representation Matters in Clinical TrialsFebruary 13th, 2023
- BEST-CLI Shows Lower Incidence of Major Adverse Limb Events or Death with Surgical Bypass Versus Endovascular Treatment in CLTI Patients with Adequate GSVJanuary 23rd, 2023
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: